tiprankstipranks
Theriva Biologics, Inc. (TOVX)
:TOVX
US Market

Theriva Biologics (TOVX) Income Statement

Compare
1,075 Followers

Theriva Biologics Income Statement

Last quarter (Q3 2024), Theriva Biologics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Theriva Biologics's net income was $-7.73M. See Theriva Biologics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -135.00K$ -268.00K$ -87.00K$ -201.00K$ -240.00K
Operating Expenses
$ 21.43M$ 21.58M$ 14.27M$ 10.16M$ 15.66M
Depreciation and Amortization
$ 135.00K$ 268.00K$ 87.00K$ 201.00K$ 240.00K
EBITDA
$ -19.85M$ -21.58M$ -14.19M$ -9.96M$ -15.42M
Operating Income
$ -21.43M$ -21.58M$ -14.27M$ -10.16M$ -15.66M
Other Income/Expenses
$ 1.44M$ 471.00K$ 6.00K$ 44.00K$ 283.00K
Pretax Income
$ -19.99M$ -21.11M$ -14.27M$ -10.12M$ -15.38M
Net Income
$ -18.35M$ -19.68M$ -14.17M$ -10.00M$ -15.02M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -28.49$ -32.11$ -1.16$ -5.26$ -9.14
Diluted EPS
$ -28.48$ -32.11$ -1.16$ -5.26$ -9.14
Weighted Average Shares Outstanding
644.00K 613.09K 12.19M 1.90M 1.64M
Weighted Average Shares Outstanding (Diluted)
644.28K 613.09K 12.19M 1.90M 1.64M
Currency in USD

Theriva Biologics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis